Management of Patients With High C-reactive Protein After Scheduled Resection of Colorectal Cancer
GESPACE
1 other identifier
interventional
105
1 country
1
Brief Summary
Anastomotic fistula is the most feared complication after surgical resection of colorectal cancer (CCR). It occurs in 6 to 15% of patients. Beyond the risk of death in the immediate postoperative period, the pain that it induces, the resources required for its management, the need for stomata with a negative impact on patients' quality of life and the prolongation of hospitalization, it also has a now-recognized adverse effect on long-term survival. The early detection of this complication may limit its impact. C-reactive protein (CRP) has proved to be an early, reliable marker of the onset of infectious complications of colorectal surgery. However, the diagnostic procedure to implement in these patients is not at all codified, since this population concerned by systematic CRP assay in the postoperative period is very recent. The procedures to implement in these patients so that they can obtain the maximal benefit of an early diagnosis have not yet been established. An algorithm for the proactive clinical management must be drawn up to be able to confirm or rule out the presence of a fistula as soon as a high level of CRP is detected, and to propose a quick treatment to ensure that patients benefit from this early diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2017
CompletedFirst Posted
Study publicly available on registry
March 31, 2017
CompletedStudy Start
First participant enrolled
April 17, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2021
CompletedFebruary 6, 2026
February 1, 2026
4.5 years
March 27, 2017
February 4, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
proportion of patients with total hospitalization of less than 15 days during the first postoperative month
45 days
Study Arms (1)
Patients who underwent open decompression surgery
OTHERInterventions
blood sample will be collected
Eligibility Criteria
You may qualify if:
- patients aged 18 and older,
- with a CRP level \> 140 mg/L at D3 or CRP \> 125 mg/L at D4 following colon and/or rectal resection with anastomosis (protected or not by an upstream stoma)
- without clinical signs of severe peritonitis (fever, severe sepsis, generalized abdominal contracture)
- who have provided written informed consent.
You may not qualify if:
- patients who have undergone intraperitoneal chemotherapy in the context of the surgical treatment for peritoneal carcinomatosis
- patients with a diagnosis of another infection that could explain the high CRP level,
- patients who underwent eventration repair at the time of the colorectal resection
- patients with an obvious indication for revisit surgery
- persons without health insurance cover
- adults under guardianship
- pregnant or beast-feeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu de Dijon
Dijon, 21079, France
Related Publications (1)
Gozalichvili D, Fournel I, Sow AK, Guiraud A, Moreno-Lopez N, Orry D, Facy O, Ortega-Deballon P. Management of patients with high C-reactive protein levels after elective colorectal surgery: Pilot study on a proactive diagnostic and therapeutic approach (GESPACE). J Visc Surg. 2024 Aug;161(4):237-243. doi: 10.1016/j.jviscsurg.2024.06.002. Epub 2024 Jun 21.
PMID: 38908988RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 27, 2017
First Posted
March 31, 2017
Study Start
April 17, 2017
Primary Completion
October 1, 2021
Study Completion
December 15, 2021
Last Updated
February 6, 2026
Record last verified: 2026-02